PGNY

PGNY

USD

Progyny Inc. Common Stock

$18.590+0.310 (1.696%)

Real-time Price

Healthcare
Healthcare Plans
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$18.280

High

$18.840

Low

$18.030

Volume

0.61M

Company Fundamentals

Market Cap

1.6B

Industry

Healthcare Plans

Country

United States

Trading Stats

Avg Volume

1.31M

Exchange

NMS

Currency

USD

52-Week Range

Low $13.39Current $18.590High $26.76

AI Analysis Report

Last updated: Nov 3, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders

What's Happening With Progyny Right Now

Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash

Related News

GlobeNewswire

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,

View more
GlobeNewswire

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs

View more
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
BusinessWire

Transcarent Experience Store Expansion: More Options for Women's Health

Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the

View more
Transcarent Experience Store Expansion: More Options for Women's Health
GlobeNewswire

Progyny CEO Named World Economic Forum Champion for Women's Health

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a

View more
Progyny CEO Named World Economic Forum Champion for Women's Health

AI PredictionBeta

AI Recommendation

Bullish

Updated at: Nov 4, 2025, 05:26 PM

BearishNeutralBullish

64.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Moderate
Trading Guide

Entry Point

$18.21

Take Profit

$19.66

Stop Loss

$16.58

Key Factors

RSI at 71.8 indicates overbought conditions
PDI 12.5 is above MDI 4.9 with ADX 20.3, suggesting bullish trend
Trading volume is 6.9x average (14,478), indicating extremely strong buying pressure
MACD 0.0379 is above signal line 0.0101, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.